3.0.0 3299 2023-01-15T07:32:53Z 2023-01-15T07:32:53Z House H HR 2003-10-15 108 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2003-10-27T18:50:29Z Referred to 2003-10-15T17:00:45Z hswm00 Ways and Means Committee House Standing hswm02 Health Subcommittee Referred to 2003-10-20T20:57:16Z Referred to 2003-10-15T17:00:50Z 2003-10-27 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2003-10-20 hswm02 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2003-10-15 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2003-10-15 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100-A 9 Library of Congress 2003-10-15 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2003-10-15 Sponsor introductory remarks on measure. (CR E2041) IntroReferral B00100 9 Library of Congress 2003-10-15 Introduced in House IntroReferral Intro-H 9 Library of Congress 2003-10-15 Introduced in House IntroReferral 1000 9 Library of Congress L000557 Rep. Larson, John B. [D-CT-1] JOHN LARSON D CT B. 1 N C001055 Rep. Case, Ed [D-HI-2] Ed Case D HI 2 2003-11-21 False H001031 Rep. Hoeffel, Joseph M. [D-PA-13] JOSEPH HOEFFEL D PA M. 13 2003-11-21 False M000933 Rep. Moran, James P. [D-VA-8] JAMES MORAN D VA P. 8 2003-11-25 False F000392 Rep. Frost, Martin [D-TX-24] MARTIN FROST D TX 24 2003-11-25 False C000191 Rep. Carson, Julia [D-IN-7] JULIA CARSON D IN 7 2003-11-25 False C000754 Rep. Cooper, Jim [D-TN-5] JAMES COOPER D TN H. 5 2003-11-25 False E000287 Rep. Emanuel, Rahm [D-IL-5] Rahm Emanuel D IL 5 2003-12-08 False K000172 Rep. Kildee, Dale E. [D-MI-5] DALE KILDEE D MI E. 5 2003-12-08 False U000039 Rep. Udall, Tom [D-NM-3] TOM UDALL D NM 3 2003-12-08 False M000725 Rep. Miller, George [D-CA-7] GEORGE MILLER D CA 7 2003-12-08 False O000006 Rep. Oberstar, James L. [D-MN-8] JAMES OBERSTAR D MN L. 8 2003-12-08 False H000067 Rep. Hall, Ralph M. [R-TX-4] RALPH HALL R TX M. 4 2004-01-27 False C000984 Rep. Cummings, Elijah E. [D-MD-7] ELIJAH CUMMINGS D MD E. 7 2004-01-27 False D000216 Rep. DeLauro, Rosa L. [D-CT-3] ROSA DELAURO D CT 3 2004-01-27 False F000116 Rep. Filner, Bob [D-CA-51] BOB FILNER D CA 51 2004-01-27 False H000627 Rep. Hinchey, Maurice D. [D-NY-22] MAURICE HINCHEY D NY D. 22 2004-02-10 False L000560 Rep. Larsen, Rick [D-WA-2] RICK LARSEN D WA 2 2004-02-26 False G000551 Rep. Grijalva, Raúl M. [D-AZ-7] Raúl Grijalva D AZ M. 7 2004-06-22 False N000002 Rep. Nadler, Jerrold [D-NY-8] JERROLD NADLER D NY 8 2004-09-30 False Health Ambulatory care Commerce Congress Congressional reporting requirements Consumer complaints Consumer protection Drug industry Fines (Penalties) Government Operations and Politics Government and business Government contractors Law Medicare Ombudsman Pharmaceutical research Pharmacies Physicians Prescription pricing Price discrimination Product development Restrictive trade practices Science, Technology, Communications Social Welfare Subcontractors Health 00 2003-10-15 Introduced in House 2003-11-03T20:55:10Z Medicare Prescription Drug Price Negotiation Act - Requires each participating manufacturer of a covered outpatient drug to make such drugs available for purchase by any qualified Federal health care provider, by each pharmacy, and by each provider of services, physician, practitioner, and supplier under the Medicare program at a price that the Secretary of Health and Human Services, in conjunction with the Secretary of Defense and the Secretary of Veterans Affairs, negotiates with the manufacturer. Provides that the amount of a covered outpatient drug that a participating manufacturer shall make available for purchase is equal to the sum of the aggregate amounts of the covered outpatient drug dispensed by pharmacies to Medicare beneficiaries plus those dispensed through qualified Federal health care providers.

Requires that, in conducting negotiations with participating manufacturers, the Secretary take into account the goal of promoting the development of breakthrough drugs.

Requires the United States to exclude from Government contracting and subcontracting, for a period of time, a manufacturer of drugs or biologicals that does not comply with this Act.

Directs the Secretary to establish a mechanism (such as an ombudsman) for the resolution of disputes between Medicare beneficiaries and prescription drug resellers and drug manufacturers in order to protect such beneficiaries and to ensure that: (1) prescription drug resellers are not artifically increasing prices charged to Medicare beneficiaries (above those negotiated under this Act) in places (such as rural areas) where there is less competition; and (2) such resellers are not colluding on prices in areas with more potential significant competition.

]]> Medicare Prescription Drug Price Negotiation Act Display Title Medicare Prescription Drug Price Negotiation Act Official Title as Introduced To provide for prescription drugs at reduced prices to Medicare beneficiaries. Introduced in House IH Short Titles as Introduced Medicare Prescription Drug Price Negotiation Act Introduced in House 2003-10-15T04:00:00Z 2003-10-27 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.